SCHEMBL4961968

SCHEMBL4961968

Cc1ccccc1N(C(=O)[C@H]1CCCNC1)C1CCCCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.58
OPRM1 P35372 5/20 0.54
CDK9 P50750 1/20 0.41
SLC6A2 P23975 5/20 0.41
SLC6A4 P31645 5/20 0.41
SLC6A3 Q01959 4/20 0.41
RPLP1 P05386 2/20 0.40
RPLP0 P05388 2/20 0.40
RPS17 P08708 2/20 0.40
RPSA P08865 2/20 0.40
RPS2 P15880 2/20 0.40
RPL35A P18077 2/20 0.40
RPL7 P18124 2/20 0.40
RPL17 P18621 2/20 0.40
RPS4Y1 P22090 2/20 0.40
RPS3 P23396 2/20 0.40
RPS12 P25398 2/20 0.40
RPL13 P26373 2/20 0.40
RPL10 P27635 2/20 0.40
RPL12 P30050 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4962054 0.85 OPRM1 (0.40) LMNAOPRM1CDK9SLC6A2SLC6A4
SCHEMBL4960487 0.84 OPRM1 (0.39) LMNAOPRM1CDK9SLC6A2SLC6A4
SCHEMBL4961286 0.83 SLC6A2 (0.50) LMNAOPRM1CDK9SLC6A2SLC6A4
SCHEMBL4962814 0.82 CHRM2 (0.52) LMNACDK9SLC6A2SLC6A4SLC6A3
SCHEMBL4963040 0.82 CHRM2 (0.52) LMNACDK9SLC6A2SLC6A4SLC6A3
SCHEMBL4963032 0.82 OPRM1 (0.38) LMNAOPRM1CDK9SLC6A1SLC6A11
SCHEMBL4962731 0.79 TRPM8 (0.41) CDK9SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL4961341 0.77 ALDH1A1 (0.55) LMNASMN1; SMN2
SCHEMBL4961872 0.75 SLC6A2 (0.46) LMNACDK9SLC6A2SLC6A4SLC6A3
SCHEMBL4960293 0.75 TRPM8 (0.50) CDK9RPLP1RPLP0RPS17RPSA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758580-A4 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORP (US) 2008-01-16 EP claimed
EP-1758580-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS Incyte Corporation (US) 2007-03-07 EP claimed
WO-2006012226-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2006-02-02 WO claimed
EP-1758580-A4 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORP (US) 2008-01-16 EP disclosed
EP-1758580-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS Incyte Corporation (US) 2007-03-07 EP disclosed
WO-2006012226-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2006-02-02 WO disclosed